Report Overview
The Phage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Product Type Insights
Global markets are presented by Phage Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Phage Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Phage Therapy segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Phage Therapy market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Phage Therapy market.
Phage Therapy Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Phage Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Phage Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Phage Therapy by Type
- 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
- 1.2.2 DsDNA Bacteriophage
- 1.2.3 SsDNA Bacteriophage
- 1.2.4 SsRNA Bacteriophage
- 1.2.5 Others
- 2.3 Phage Therapy by Application
- 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
- 2.3.2 Animal Health
- 2.3.3 Aquaculture
- 2.3.4 Agriculture
- 2.3.5 Food Industry
- 2.3.6 Human Health
- 2.3.7 Others
- 2.4 Assumptions and Limitations
- 3 Phage Therapy Breakdown Data by Type
- 3.1 Global Phage Therapy Historic Market Size by Type (2018-2023)
- 3.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028)
- 4 Phage Therapy Breakdown Data by Application
- 4.1 Global Phage Therapy Historic Market Size by Application (2018-2023)
- 4.2 Global Phage Therapy Forecasted Market Size by Application (2018-2023)
- 5 Global Growth Trends
- 5.1 Global Phage Therapy Market Perspective (2018-2029)
- 5.2 Global Phage Therapy Growth Trends by Region
- 5.2.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
- 5.2.2 Phage Therapy Historic Market Size by Region (2018-2023)
- 5.2.3 Phage Therapy Forecasted Market Size by Region (2024-2029)
- 5.3 Phage Therapy Market Dynamics
- 5.3.1 Phage Therapy Industry Trends
- 5.3.2 Phage Therapy Market Drivers
- 5.3.3 Phage Therapy Market Challenges
- 5.3.4 Phage Therapy Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Phage Therapy Players by Revenue
- 6.1.1 Global Top Phage Therapy Players by Revenue (2018-2023)
- 6.1.2 Global Phage Therapy Revenue Market Share by Players (2018-2023)
- 6.2 Global Phage Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
- 6.3 Global Key Players of Phage Therapy Head office and Area Served
- 6.4 Global Phage Therapy Players, Product Type & Application
- 6.5 Global Phage Therapy Players, Date of Enter into This Industry
- 6.6 Global Phage Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 6.1 Global Top Phage Therapy Players by Revenue
- 7 North America
- 7.1 North America Phage Therapy Market Size (2018-2029)
- 7.2 North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 7.3 North America Phage Therapy Market Size by Country (2018-2023)
- 7.4 North America Phage Therapy Market Size by Country (2024-2029)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Phage Therapy Market Size (2018-2029)
- 8.2 Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 8.3 Europe Phage Therapy Market Size by Country (2018-2023)
- 8.4 Europe Phage Therapy Market Size by Country (2024-2029)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Phage Therapy Market Size (2018-2029)
- 9.2 Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 9.3 Asia-Pacific Phage Therapy Market Size by Country (2018-2023)
- 9.4 Asia-Pacific Phage Therapy Market Size by Country (2024-2029)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Phage Therapy Market Size (2018-2029)
- 10.2 Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 10.3 Latin America Phage Therapy Market Size by Country (2018-2023)
- 10.4 Latin America Phage Therapy Market Size by Country (2024-2029)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Phage Therapy Market Size (2018-2029)
- 11.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 11.3 Middle East & Africa Phage Therapy Market Size by Country (2018-2023)
- 11.4 Middle East & Africa Phage Therapy Market Size by Country (2024-2029)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 NPO Microgen
- 11.1.1 NPO Microgen Company Detail
- 11.1.2 NPO Microgen Business Overview
- 11.1.3 NPO Microgen Phage Therapy Introduction
- 11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022)
- 11.1.5 NPO Microgen Recent Development
- 11.2 Proteon Pharmaceuticals
- 11.2.1 Proteon Pharmaceuticals Company Detail
- 11.2.2 Proteon Pharmaceuticals Business Overview
- 11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
- 11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022)
- 11.2.5 Proteon Pharmaceuticals Recent Development
- 11.3 Phagelux
- 11.3.1 Phagelux Company Detail
- 11.3.2 Phagelux Business Overview
- 11.3.3 Phagelux Phage Therapy Introduction
- 11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022)
- 11.3.5 Phagelux Recent Development
- 11.4 Intralytix
- 11.4.1 Intralytix Company Detail
- 11.4.2 Intralytix Business Overview
- 11.4.3 Intralytix Phage Therapy Introduction
- 11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022)
- 11.4.5 Intralytix Recent Development
- 11.5 Micreos
- 11.5.1 Micreos Company Detail
- 11.5.2 Micreos Business Overview
- 11.5.3 Micreos Phage Therapy Introduction
- 11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022)
- 11.5.5 Micreos Recent Development
- 11.6 Eliava BioPreparations
- 11.6.1 Eliava BioPreparations Company Detail
- 11.6.2 Eliava BioPreparations Business Overview
- 11.6.3 Eliava BioPreparations Phage Therapy Introduction
- 11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022)
- 11.6.5 Eliava BioPreparations Recent Development
- 11.7 Locus Biosciences,Inc
- 11.7.1 Locus Biosciences,Inc Company Detail
- 11.7.2 Locus Biosciences,Inc Business Overview
- 11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
- 11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022)
- 11.7.5 Locus Biosciences,Inc Recent Development
- 11.8 Pharmex Group,LLC
- 11.8.1 Pharmex Group,LLC Company Detail
- 11.8.2 Pharmex Group,LLC Business Overview
- 11.8.3 Pharmex Group,LLC Phage Therapy Introduction
- 11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022)
- 11.8.5 Pharmex Group,LLC Recent Development
- 11.9 Pherecydes Pharma
- 11.9.1 Pherecydes Pharma Company Detail
- 11.9.2 Pherecydes Pharma Business Overview
- 11.9.3 Pherecydes Pharma Phage Therapy Introduction
- 11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022)
- 11.9.5 Pherecydes Pharma Recent Development
- 11.10 APS Biocontrol Ltd. (APS)
- 11.10.1 APS Biocontrol Ltd. (APS) Company Detail
- 11.10.2 APS Biocontrol Ltd. (APS) Business Overview
- 11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
- 11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022)
- 11.10.5 APS Biocontrol Ltd. (APS) Recent Development
- 11.11 Qingdao Phagepharm Bio-tech
- 11.11.1 Qingdao Phagepharm Bio-tech Company Detail
- 11.11.2 Qingdao Phagepharm Bio-tech Business Overview
- 11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
- 11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022)
- 11.11.5 Qingdao Phagepharm Bio-tech Recent Development
- 11.12 Fixed-Phage Limited
- 11.12.1 Fixed-Phage Limited Company Detail
- 11.12.2 Fixed-Phage Limited Business Overview
- 11.12.3 Fixed-Phage Limited Phage Therapy Introduction
- 11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022)
- 11.12.5 Fixed-Phage Limited Recent Development
- 11.13 Zeptometrix
- 11.13.1 Zeptometrix Company Detail
- 11.13.2 Zeptometrix Business Overview
- 11.13.3 Zeptometrix Phage Therapy Introduction
- 11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022)
- 11.13.5 Zeptometrix Recent Development
- 11.14 Phage International, Inc.
- 11.14.1 Phage International, Inc. Company Detail
- 11.14.2 Phage International, Inc. Business Overview
- 11.14.3 Phage International, Inc. Phage Therapy Introduction
- 11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022)
- 11.14.5 Phage International, Inc. Recent Development
- 11.15 MicroMir
- 11.15.1 MicroMir Company Detail
- 11.15.2 MicroMir Business Overview
- 11.15.3 MicroMir Phage Therapy Introduction
- 11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022)
- 11.15.5 MicroMir Recent Development
- 11.16 iNtODEWORLD, Inc.
- 11.16.1 iNtODEWORLD, Inc. Company Detail
- 11.16.2 iNtODEWORLD, Inc. Business Overview
- 11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
- 11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022)
- 11.16.5 iNtODEWORLD, Inc. Recent Development
- 11.17 NEXTBIOTICS
- 11.17.1 NEXTBIOTICS Company Detail
- 11.17.2 NEXTBIOTICS Business Overview
- 11.17.3 NEXTBIOTICS Phage Therapy Introduction
- 11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022)
- 11.17.5 NEXTBIOTICS Recent Development
- 11.18 Armata Pharmaceuticals, Inc.
- 11.18.1 Armata Pharmaceuticals, Inc. Company Detail
- 11.18.2 Armata Pharmaceuticals, Inc. Business Overview
- 11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
- 11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022)
- 11.18.5 Armata Pharmaceuticals, Inc. Recent Development
- 11.19 Innophage
- 11.19.1 Innophage Company Detail
- 11.19.2 Innophage Business Overview
- 11.19.3 Innophage Phage Therapy Introduction
- 11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022)
- 11.19.5 Innophage Recent Development
- 11.20 Adaptive Phage Therapeutics
- 11.20.1 Adaptive Phage Therapeutics Company Detail
- 11.20.2 Adaptive Phage Therapeutics Business Overview
- 11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
- 11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022)
- 11.20.5 Adaptive Phage Therapeutics Recent Development
- 11.21 TechnoPhage
- 11.21.1 TechnoPhage Company Detail
- 11.21.2 TechnoPhage Business Overview
- 11.21.3 TechnoPhage Phage Therapy Introduction
- 11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022)
- 11.21.5 TechnoPhage Recent Development
- 11.1 NPO Microgen
- 13 Report Conclusion
- 14 Disclaimer